Similar articles

• [Life-threatening ketoacidosis in a 25-year-old woman treated with sodium-glucose cotransporter 2 inhibitor].

  Lindberg MJ, Kristensen FB, Yildiz A. Lindberg MJ, et al. Ugeskr Laeger. 2016 Nov 21;178(47):V07160477. Ugeskr Laeger. 2016. PMID: 27908315 Danish.
• Sodium-glucose cotransporter 2 inhibitors and diabetic ketoacidosis.

  Bloomgarden ZT. Bloomgarden ZT. J Diabetes. 2016 Mar;8(2):175-6. doi: 10.1111/1753-0407.12353. Epub 2015 Dec 29. J Diabetes. 2016. PMID: 26611882 No abstract available.
• Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report.

  Lee IH, Ahn DJ. Lee IH, et al. Medicine (Baltimore). 2020 May 22;99(21):e20228. doi: 10.1097/MD.0000000000020228. Medicine (Baltimore). 2020. PMID: 32481295 Free PMC article.
• Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature.

  Hernandez-Quiles C, Ramirez-Duque N, Acosta-Delgado D. Hernandez-Quiles C, et al. Curr Diabetes Rev. 2019;15(4):259-262. doi: 10.2174/1573399814666180726114044. Curr Diabetes Rev. 2019. PMID: 30047331 Review.
• Low carbohydrate diet while taking dapagliflozin: A case report and review of literature.

  Paul N, Jonklaas J. Paul N, et al. Diabetes Metab Syndr. 2021 Jan-Feb;15(1):361-363. doi: 10.1016/j.dsx.2021.01.016. Epub 2021 Jan 23. Diabetes Metab Syndr. 2021. PMID: 33517150 Review. No abstract available.